|
Post by chmith27 on Jul 10, 2014 14:48:07 GMT -5
by cashing in on success do you mean the $40/share we'd be at now and the $80/share we'd be looking at after a partner if not for massive dilutions and obvious blunders by mngmnt? Did MNKD spend too much $$ to bring a potential blockbuster into a market with well entrenched, accepted treatment? I don't think so. The company had a huge burden of proof to bear. Were the 2 CRLs obvious blunders by management? 1 CRL is not uncommon. I agree 2 is unusual, but only in the sense that most companies give up after 2. Swapping out the inhaler in the middle of PIII I suppose can be deemed a blunder. The alternative would have been to re-run PIII, which would have cost more $$ and delays. A judgment call by management, and they lost. How obvious a blunder that is (without hindsight), I am not prepared to second guess. The near death experience caused the stock to tank, resulting in the painful, massive dilution to long term holders. However, consider the alternative to near death: death. "Swapping out the inhaler in the middle of PIII I suppose can be deemed a blunder". you suppose? clearly a HUGE "misunderstanding" by mnkd. look i'm not going to get into this debate which has been rehashed ad nosium. my point was to jpg, there is good reason to be critical at times of mngmt for obvious misleadings and "misunderstandings", and to not make false statements about the other board approach to these criticisms. that was it. it's plain and simple. several of us represent the other board as well so it's pointed at us, albeit not intentionally nor with any real venom. but that brings up an interesting observation about some people that makes me ponder. why is it that when anyone around this board so much as mentions a. mann's mngmnt team in a critical manner, everyone feels like they have to come to al's defense? it is sorta cult-like, and i'm not saying that's wrong, but it is sorta odd to me. i went to the ASM last year just to see and meet al mann. i really liked the guy then and like him ever the more now. but if you guys can't admit that mngmnt has screwed up on several occasions and are worthy of significant criticism by the other board, then maybe some of your thinking is clouded by your crush on al? again, i'll leave the last comments to you guys but all i'm saying is don't say incorrect things about the other proboard. no one is bashing al and no one is getting banned.
|
|
|
Post by jpg on Jul 10, 2014 15:01:05 GMT -5
Hi Chmith,
I stand by my comments and to the best of my knowledge everything I said was true and correct. 2 posters recently got banned on the other proboard for politely pointing out to some on the boards that they were being disrespectful to A. Mann and that interpretation of 'facts' can be subjective.
Your a.) is subjective but to me some of the comments there cross a line. As for your b.) The board administrator publicly stated he was banning 2 individuals and I haven't seen them post there since they were banned...
JPG
|
|
|
Post by alcc on Jul 10, 2014 17:04:46 GMT -5
my point was to jpg, there is good reason to be critical at times of mngmt for obvious misleadings and "misunderstandings", and to not make false statements about the other board approach to these criticisms. that was it. By all means be vigilant and critical of management. But "misleadings and 'misunderstandings'"? That implies intent and bad faith. I am curious, what does Al Mann, the biggest shareholder, have to gain by misleading you or anyone else? It's not like he could dump his shares before you can. As to "obvious blunders", I've made my shares of blunders. Every single one of them looked obvious -- in hindsight.
|
|
|
Post by chmith27 on Jul 10, 2014 17:31:53 GMT -5
jpg- pax begged to be banned. he actually begged for it- i remember this conversation now so you are correct on that. it ultimately had nothing to do with content but pure annoyance. and pax was being disruptive because he thought another dude was banned, which he was not banned. then there was another exchange involving inhale on the YMB but by that point i wasn't reading the thread like many aren't reading this. nobody gets banned from speaking highly of al/mngmnt, that was my point. anyway, you guys keep having your circle jerk with al and i'll sit this thread out. no hard feelings just a friendly diff of opinions, and those usually don't change too much anyway. cheers. -chad
|
|
|
Post by chmith27 on Jul 10, 2014 17:33:18 GMT -5
my point was to jpg, there is good reason to be critical at times of mngmt for obvious misleadings and "misunderstandings", and to not make false statements about the other board approach to these criticisms. that was it. By all means be vigilant and critical of management. But "misleadings and 'misunderstandings'"? That implies intent and bad faith. I am curious, what does Al Mann, the biggest shareholder, have to gain by misleading you or anyone else? It's not like he could dump his shares before you can. As to "obvious blunders", I've made my shares of blunders. Every single one of them looked obvious -- in hindsight. one more thing.... are you are going to tell me the middle eastern country that wants to put in a 200mil order wasn't misleading? gotcha. cheers.
|
|
|
Post by alcc on Jul 10, 2014 19:12:55 GMT -5
I assume you are not claiming specific knowledge that no such discussion (with a "middle-eastern country that wants to put in a 200mil order") ever took place. If you have such knowledge, then the statement is an outright lie, not merely misleading. If, by misleading, you really meant "should not have been said," whether or not the statement is true, I would agree with you. You got me. I applaud your high ethical standards. Cheers.
|
|
|
Post by coco on Jul 10, 2014 19:48:30 GMT -5
Everyone, we are all in this together. Whether we like it or not, we have one common bond which is mnkd. No need to argue. If I want to listen to bantering back and forth, I can get that from yahoo or investor village. We are all educated here and want the samething. I come from a place of peace. Please don't take this the wrong way. Coco
|
|
|
Post by mannmade on Jul 10, 2014 21:25:43 GMT -5
Actually I believe it was a 3rd world country (not specified which country). Since ad not heard anything on the subject in a while, I personally asked Hakan about it after the last shareholder meeting to see if it was still topical given the time since the last crl. I was told that yes they are still in the conversation but would likely not happen until about six months after approval. Did not get a chance to follow up on that answer.
|
|
|
Post by liane on Jul 10, 2014 21:29:50 GMT -5
Everyone, we are all in this together. Whether we like it or not, we have one common bond which is mnkd. No need to argue. If I want to listen to bantering back and forth, I can get that from yahoo or investor village. We are all educated here and want the samething. I come from a place of peace. Please don't take this the wrong way. Coco Thank you coco. This thread has really devolved. I'm hoping everyone takes the hint and moves on to more productive discussion.
|
|
|
Post by obamayoumama on Jul 10, 2014 22:04:31 GMT -5
I think that when a Saudi Prince calls you up and says that they will buy 200 million of your product when it is FDA approved, you might get excited too. When attorneys get involved, and ask that your partner handle those issues, it would make sense that the order is still coming, but we might have to wait for six months.
|
|
|
Post by 1 percenter on Jul 10, 2014 22:11:51 GMT -5
I think that when a Saudi Prince calls you up and says that they will buy 200 million of your product when it is FDA approved, you might get excited too. When attorneys get involved, and ask that your partner handle those issues, it would make sense that the order is still coming, but we might have to wait for six months. If it was Syria, you can forget about that order.
|
|
|
Post by kc on Jul 11, 2014 21:23:16 GMT -5
Saudi might not like Alfred Mann and his partnership with the Technion in Haifa, Israel. Mann has funded a Medical technology institute at the Technion. It's Israel's MIT. I wonder if Techosphere comes from the Technion? www.amitechnion.comI think that when a Saudi Prince calls you up and says that they will buy 200 million of your product when it is FDA approved, you might get excited too. When attorneys get involved, and ask that your partner handle those issues, it would make sense that the order is still coming, but we might have to wait for six months. If it was Syria, you can forget about that order.
|
|
|
Post by kc on Jul 11, 2014 21:26:09 GMT -5
AMIT is the Technion hub for biomedical innovation; it supports the development and commercialization of exceptional inventions conceived by Technion researchers with a mission to bring to market promising biomedical technology.
Established in 2006 by the Technion - Israel Institute of Technology, one of Israel's leading academic centers, and by Dr. Alfred E. Mann, an American entrepreneur and philanthropist, the institute aspires to bridge the eminent gap between applied academic research and commercial success.
AMIT pursues the creation of substantial value for patients, by nurturing research creativity with structured development and commercialization.
By creating significant clinical and commercial value, we position startups for later stage industry transfers, generating notable returns for stakeholders, and enabling sustainable nourishing of newer inventions.
AMIT takes a lead role in driving its projects and startups forward, providing everything needed from A to Z: manpower, infrastructure and equipment, intellectual property management, pre-clinical and clinical management, regulatory and QA management, marketing, business development and more.
We do so with the determination of our multidisciplinary core team of employees and consultants, led by Dr. Zeev Gilkis, a former corporate investment manager and a director of several high-tech and biotech companies.
AMIT operates under the common control of the Alfred E. Mann Foundation for Biomedical Engineering (AMFBE), the Technion
Dr. Alfred E. Mann
Dr. Alfred E. Mann is an American entrepreneur and philanthropist, who founded and largely funded 17 companies in his career. Nine were acquired at an overall total of almost $8 billion, and two companies became public.
Dr. Mann founded and led some of the pioneering medical device companies of our times- In 1972 he founded Pacesetter Systems, Inc., which developed, manufactured and distributed cardiac pacemakers, until 1985 when it was acquired by Siemens, AG. Pacesetter is now the Cardiac Rhythm Management unit of St. Jude Medical.
In 1993 he founded Minimed (later acquired by Medtronic), which develops, manufactures and distributes microinfusion systems and continuous glucose monitoring systems that have revolutionized the treatment of Type 1 diabetes.
In 1993 he also founded Advanced Bionics Corporation (AB) (later acquired by Boston Scientific Corporation), which developed neurostimulation devices for various neural deficits, including cochlear stimulators.
Some of the companies currently operating within the Al Mann family of companies include:
MannKind Corporation, which develops novel therapeutics and drug delivery technologies for treatment primarily of diabetes, metabolic disease and cancer; Bioness, which develops and manufactures systems to address neural deficits and to restore controlled function of paralyzed limbs; Second Sight, which is developing a visual prosthesis to restore sight to the blind; IncuMed, which is developing novel percutaneous seals for various applications; PerQFlo, which is developing drug delivery systems; Quallion, which develops, manufactures and markets advanced batteries for medical, aerospace and military applications; Stellar Microelectronics, which produces micro-circuit assemblies. Dr. Mann holds B.A. and M.S. degrees in physics from the University of California, Los Angeles and honorary doctorate degrees from the University of Southern California, The Johns Hopkins University, Western University and the Technion, as well as, Research Professor, University of Southern California, and Adjunct Professor, Dept. of Bioengineering, University of California Los Angeles.
Dr. Mann is a member of the USA National Academy of Engineering and has received numerous honors and awards from the private and public sectors. and the American Technion Society (ATS).
|
|
|
Post by brentie on Jul 11, 2014 22:35:54 GMT -5
|
|
|
Post by lynn on Jul 11, 2014 23:13:51 GMT -5
Wow Brentie !! So much for getting Mannkind off my mind for the weekend !! Great find !! I just shared that article on Facebook , I think 97% of my friends must think I've lost my mind ,) but regardless of investing , this is a worthy read & I must admit, just his last ride w/ Mannkind ( when the story unfolds ,)) could make a great movie , add in his life story & it could very well be a Block Buster Time will tell .. Lynn
|
|